Skip to content
Search

Latest Stories

Cannabis in children's candy: Haribo recalls sweets

Forensic testing later revealed the presence of cannabis.

Haribo's Sweet Shock: Cannabis Contamination Triggers Recall

Consumers in the Netherlands are being urged to check any 1kg packs of Haribo Happy Cola F!ZZ sweets

iStock

Haribo has recalled a batch of its Happy Cola F!ZZ sweets in the Netherlands after traces of cannabis were discovered in several packs. The recall was prompted after multiple individuals, including children, reported feeling unwell after consuming the sweets.

According to the Netherlands Food and Consumer Product Safety Authority (NVWA), three 1kg packs were linked to complaints of dizziness and other health-related symptoms. The NVWA confirmed that the affected sweets were genuine Haribo products and said the recall was being carried out as a precautionary measure.


A spokesperson for the NVWA told Dutch news agency ANP that it was still unclear how the cannabis ended up in the sweets. “The police are investigating the matter further,” the spokesperson said.

Dutch police confirmed that a couple from the Twente region brought in a packet of the cola-bottle-shaped sweets after their children became ill upon eating them. Forensic testing later revealed the presence of cannabis.

Police spokesperson Chantal Westerhoff said, “We want to know exactly how it got into the candy and, of course, how the bags ended up in the store.”

Haribo stated that the recall only affects 1kg bags of the Happy Cola F!ZZ sweets with a specific product code and a use-by date of January 2026. Consumers who purchased the affected products are eligible for a full refund.

Patrick Tax, vice-president of marketing at Haribo, said the issue was limited to a small number of cases in the eastern part of the Netherlands. “The safety of our consumers is our highest priority and Haribo takes this incident very seriously,” he said.

Tax added that Haribo is cooperating closely with the Dutch authorities to assist in the ongoing investigation. “This is a live issue and we are working closely with the Dutch authorities to support their investigation and establish the facts,” he told Agence France-Presse.

The NVWA has issued a clear warning to consumers not to eat the sweets from the affected batch.

In a separate case in 2023, six children aged between four and 14 became unwell in The Hague after consuming sweets that contained THC, one of the active substances in cannabis. However, the products involved in that incident were not regular commercial items.

Authorities have noted a rise in cases where drug smugglers disguise cannabis-laced products as common confectionery, including popular brands. There have also been reports of imitation sweets resembling Haribo products being sold online with added THC.

The investigation into how cannabis was introduced into the recalled Haribo sweets is ongoing. Police and food safety officials continue to examine supply chain links and retail distribution to identify the source of contamination.

For now, consumers in the Netherlands are being urged to check any 1kg packs of Haribo Happy Cola F!ZZ sweets they may have purchased and return them if they match the affected batch.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less